...The companies expanded their 2003 deal to give NascaCell non-exclusive rights to use Archemix’s aptamer technology...
...to contract NascaCell to generate aptamers for Archemix’s own applications. Archemix Corp. , Cambridge, Mass. NascaCell GmbH...

...NascaCell will generate Microbodies against up to four undisclosed targets provided by Boehringer. NascaCell will receive...
...using NascaCell's Microbody technology. Further terms were not disclosed. Boehringer Ingelheim GmbH , Ingelheim, Germany NascaCell...

...to Eyetech, now part of OSI (OSIP). Archemix later licensed certain aptamer rights to Noxxon, NascaCell...

...acids in length. NascaCell said Microbodies inhibit intracellular signal transduction and down-regulate certain metabolic proteins. NascaCell...

...subsidiary (Monheim, Germany) will use to validate crop science targets. Further terms were not disclosed. NascaCell...

...Biotechnologies GmbH , Martinsried, Germany Business: Supply/Service Hired: Andreas Jenne as CEO, formerly CEO of NascaCell...

...Kinaxo (Martinsried, Germany) hired Andreas Jenne as CEO. Previously, Jenne was CEO of aptamer company NascaCell...

...and small molecule screening technology, PSF's protein production and crystallization capabilities and NascaCell's aptamer technology. NascaCell GmbH...